Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MCLA-145 by Merus for Merkel Cell Carcinoma: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Merkel Cell Carcinoma. According to GlobalData, Phase...
MCLA-145 by Merus for Non-Small Cell Lung Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData,...
MCLA-145 by Merus for Glioblastoma Multiforme (GBM): Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData, Phase...
MCLA-145 by Merus for Anal Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Anal Cancer. According to GlobalData, Phase I...
MCLA-145 by Merus for Solid Tumor: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
MCLA-145 by Merus for Sarcomas: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Sarcomas. According to GlobalData, Phase I drugs...
MCLA-145 by Merus for Gastric Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I...
MCLA-145 by Merus for Pancreatic Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Pancreatic Cancer. According to GlobalData, Phase I...
MCLA-145 by Merus for Cervical Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Cervical Cancer. According to GlobalData, Phase I...
MCLA-145 by Merus for Colorectal Cancer: Likelihood of Approval
MCLA-145 is under clinical development by Merus and currently in Phase I for Colorectal Cancer. According to GlobalData, Phase I...